Postnatal microcephaly and retinal involvement expand the phenotype of RPL10-related disorder.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
10 2022
Historique:
revised: 16 05 2022
received: 06 02 2022
accepted: 07 07 2022
pubmed: 26 7 2022
medline: 15 9 2022
entrez: 25 7 2022
Statut: ppublish

Résumé

Hemizygous missense variants in the RPL10 gene encoding a ribosomal unit are responsible for an X-linked syndrome presenting with intellectual disability (ID), autism spectrum disorder, epilepsy, dysmorphic features, and multiple congenital anomalies. Among 15 individuals with RPL10-related disorder reported so far, only one patient had retinitis pigmentosa and microcephaly was observed in approximately half of the cases. By exome sequencing, three Italian and one Spanish male children, from three independent families, were found to carry the same hemizygous novel missense variant p.(Arg32Leu) in RPL10, inherited by their unaffected mother in all cases. The variant, not reported in gnomAD, is located in the 28S rRNA binding region, affecting an evolutionary conserved residue and predicted to disrupt the salt-bridge between Arg32 and Asp28. In addition to features consistent with RPL10-related disorder, all four boys had retinal degeneration and postnatal microcephaly. Pathogenic variants in genes responsible for inherited retinal degenerations were ruled out in all the probands. A novel missense RPL10 variant was detected in four probands with a recurrent phenotype including ID, dysmorphic features, progressive postnatal microcephaly, and retinal anomalies. The presented individuals suggest that retinopathy and postnatal microcephaly are clinical clues of RPL10-related disorder, and at least the retinal defect might be more specific for the p.(Arg32Leu) RPL10 variant, suggesting a specific genotype/phenotype correlation.

Identifiants

pubmed: 35876338
doi: 10.1002/ajmg.a.62911
pmc: PMC9545381
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3032-3040

Informations de copyright

© 2022 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Références

Mol Psychiatry. 2006 Dec;11(12):1073-84
pubmed: 16940977
Am J Med Genet A. 2022 Oct;188(10):3032-3040
pubmed: 35876338
Am J Med Genet A. 2015 Aug;167A(8):1908-12
pubmed: 25846674
BMJ Case Rep. 2013 Dec 11;2013:
pubmed: 24336587
Am J Med Genet A. 2011 Jun;155A(6):1472-5
pubmed: 21567917
Nucleic Acids Res. 2016 Jul 8;44(12):5773-84
pubmed: 27235414
Genomics. 2001 Mar 15;72(3):223-30
pubmed: 11401437
Br J Ophthalmol. 2005 Aug;89(8):1063-4
pubmed: 16024866
Eur J Hum Genet. 2014 Jul;22(7):881-7
pubmed: 24281367
BMC Bioinformatics. 2018 Dec 12;19(1):477
pubmed: 30541431
Am J Hum Genet. 2012 Feb 10;90(2):356-62
pubmed: 22284827
Nucleic Acids Res. 2020 Feb 20;48(3):1013-1028
pubmed: 31350888
Sci Rep. 2019 Dec 2;9(1):18130
pubmed: 31792295
Am J Hum Genet. 2012 Apr 6;90(4):579-90
pubmed: 22482801
Biochem J. 2017 Jan 15;474(2):195-214
pubmed: 28062837
Childs Nerv Syst. 2018 Jan;34(1):95-99
pubmed: 29167994
Genetics. 2014 Oct;198(2):723-33
pubmed: 25316788
PLoS Genet. 2019 Feb 1;15(2):e1007917
pubmed: 30707697
J Allergy Clin Immunol. 2014 Feb;133(2):529-34
pubmed: 24139496
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
J Biol Chem. 2019 Apr 5;294(14):5508-5520
pubmed: 30733333
Adv Biol Regul. 2018 Jan;67:109-127
pubmed: 28942353
Nat Rev Genet. 2016 Jan;17(1):9-18
pubmed: 26503795
Eur J Med Genet. 2018 Feb;61(2):89-93
pubmed: 29066376
Trends Genet. 2019 Oct;35(10):754-767
pubmed: 31376929
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Blood. 2015 Feb 26;125(9):1377-82
pubmed: 25575543
J Neurochem. 2019 Feb;148(3):325-347
pubmed: 30144322
Neurol Genet. 2017 May 26;3(3):e159
pubmed: 28589177
Hum Mutat. 2015 Dec;36(12):1155-8
pubmed: 26290468
Arch Intern Med. 2001 Nov 12;161(20):2447-54
pubmed: 11700157
J Mol Histol. 2009 Oct;40(5-6):361-7
pubmed: 20043235

Auteurs

Gerarda Cappuccio (G)

Department of Translational Medicine, Section of Pediatrics, Federico II University, Naples, Italy.
Telethon Institute of Genetics and Medicine, Naples, Italy.

Margherita Lucia De Bernardi (ML)

Department of Translational Medicine, Section of Pediatrics, Federico II University, Naples, Italy.

Alessia Morlando (A)

Department of Translational Medicine, Section of Pediatrics, Federico II University, Naples, Italy.

Cristina Peduto (C)

Department of Precision Health, University of Campania 'Luigi Vanvitelli', Naples, Italy.

Iris Scala (I)

Department of Translational Medicine, Section of Pediatrics, Federico II University, Naples, Italy.

Michele Pinelli (M)

Department of Translational Medicine, Section of Pediatrics, Federico II University, Naples, Italy.
Department of Molecular Medicine and Medical Biotechnology (DMMBM), Federico II University, Naples, Italy.

Emanuele Bellacchio (E)

Genetics and Rare Diseases Research Division, Bambino Gesù Children's Hospital, Rome, Italy.

Flavio Gioele Gallo (FG)

Department of Pediatric Ophthalmology, University of Salerno, Fisciano, Italy.

Adriano Magli (A)

Department of Pediatric Ophthalmology, University of Salerno, Fisciano, Italy.

Carmen Plaitano (C)

Department of Ophthalmology, A.O.U. San Giovanni Di Dio e Ruggi d'Aragona-Scuola Medica Salernitana, Salerno, Italy.

Mercedes Serrano (M)

Department of Ophthalmology and Department of Genetic and Molecular Medicine, Hospital Sant Joan de Déu, Barcelona, Spain.
U-703 Centre for Biomedical Research on Rare Diseases (CIBER-ER), Instituto de Salud Carlos III, Madrid, Spain.

Leticia Pías (L)

Department of Ophthalmology and Department of Genetic and Molecular Medicine, Hospital Sant Joan de Déu, Barcelona, Spain.

Jaume Català (J)

Department of Ophthalmology and Department of Genetic and Molecular Medicine, Hospital Sant Joan de Déu, Barcelona, Spain.

Mercè Bolasell (M)

U-703 Centre for Biomedical Research on Rare Diseases (CIBER-ER), Instituto de Salud Carlos III, Madrid, Spain.

Annalaura Torella (A)

Telethon Institute of Genetics and Medicine, Naples, Italy.
Department of Precision Health, University of Campania 'Luigi Vanvitelli', Naples, Italy.

Vincenzo Nigro (V)

Telethon Institute of Genetics and Medicine, Naples, Italy.
Department of Precision Health, University of Campania 'Luigi Vanvitelli', Naples, Italy.

Ginevra Zanni (G)

Unit of Muscular and Neurodegenerative Diseases, Department of Neurosciences, Bambino Gesù Children's Hospital, Rome, Italy.

Nicola Brunetti-Pierri (N)

Department of Translational Medicine, Section of Pediatrics, Federico II University, Naples, Italy.
Telethon Institute of Genetics and Medicine, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH